Urine-based diagnostic technologies

Trends in Biotechnology

Volumn 14, Issue 10, 1996, Pages 361-364

  Urnovitz, Howard B ^a   Murphy, William H ^b   Gottfried, Toby D ^a   Friedman Kien, Alvin E ^c  

^a Calypte Biomedical Corporation   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DETECTION; ANTIBODY RESPONSE; BIOTECHNOLOGY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOBLOTTING; INFECTION; PRIORITY JOURNAL; SHORT SURVEY; URINALYSIS;

EID: 0030272563     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-7799(96)10048-2     Document Type: Note

References (26)

1. 1 Fidler, D. P., Jr (1996) Emerging Inf. Dis. 2, 77-84
2. 2 Garrett, L. (1994) The Coming Plague: Newly Emerging Diseases in a World Out of Balance, pp. 53-70, Farrar, Straus and Giroux
3. 3 Hull, R. N., Minner, J. R. and Mascoli, C. C. (1958) Am. J. Hyg. 68, 31-44
4. 4 Shah, K. and Nathanson, N. (1976) Am. J. Epidemiol. 103, 1-12
5. 5 Leon-Monzon, M. E. and Dalakas, M. C. (1995) Ann. New York Acad. Sci. 753, 208-218
6. 6 Urnovitz, H. B. (1992) Biotech Forum Europe 9, 4-5
7. 7 Anon. (1992) LIFT 2000: Laboratory Initiatives for the Year 2000, Association of State and Territorial Public Health Laboratory Directors and Centers for Disease Control and Prevention, Washington, DC, USA
8. 8 Cao, Y. Z. et al. (1988) Lancet i, 831-832
9. 9 Kostolansky, F., Li, J. J. and Friedman-Kien, A. E. (1993) AIDS 7, 1531-1532
10. 10 Berrios, D. C. et al. (1995) Arch. Pathol. Lab. Med. 119, 139-141
11. 11 Cao, Y. Z. et al. (1989) AIDS Res. Hum. Retroviruses 5, 311-319
12. 12 Centers for Disease Control and Prevention (1989) MMWR Weekly Report 38, 1-7
13. 13 Cambridge Biotech Corporation, Package Insert: Cambridge Biotech HIV-1 Western Blot Kit, US License No. 1063, p. 19
14. 14 Chamaret, S. et al. (1992) Abstr. VIII Int. Conf. AIDS, Amsterdam 8035
15. 15 Charneau, P. et al. (1994) Virology 205, 247-253
16. 16 Urnovitz, H. B. et al. (1993) Lancet 342, 1458-1459
17. 17 Shearer, G. M. and Clerici, M. (1996) Immunol. Today 17, 21-24
18. 18 Urnovitz, H. B. and Murphy, W. H. (1996) Clin. Micro. Rev. 9, 72-99
19. 19 Gottfried, T. D. et al. (1995) Abstr. 9th Int. Cong. Immunol., San Francisco 935
20. 20 Baltch, A. L. et al. (1996) Abstr. 96th Am. Soc. Microbiol., New Orleans V-4
21. 21 Abu-Shakra, M. and Shoenfeld, Y. (1991) Immunol. Series 55, 285-313
22. 22 Centers for Disease Control and Prevention (1994) MMWR Weekly Report 43, 366-375
23. 23 Urnovitz, H. B., Gottfried, T. D. and Robison, D. J. (1996) US Patent No. 5516638
24. 24 Lerner, M. et al. (1962) J. Clin. Invest. 41, 805-815
25. 25 Alemohammad, M. M., Foley, T. J. and Cohen, H. (1993) J. Clin. Microbiol. 31, 2174-2177
26. 26 Constantine, N. T. et al. (1992) Lancet 339, 1607-1608